KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Resmed (RMD) Debt to Equity (2016 - 2025)

Historic Debt to Equity for Resmed (RMD) over the last 16 years, with Q4 2025 value amounting to $0.04.

  • Resmed's Debt to Equity rose 208046.26% to $0.04 in Q4 2025 from the same period last year, while for Dec 2025 it was $0.04, marking a year-over-year increase of 208046.26%. This contributed to the annual value of $0.0 for FY2025, which is 1849.6% down from last year.
  • As of Q4 2025, Resmed's Debt to Equity stood at $0.04, which was up 208046.26% from $0.04 recorded in Q3 2025.
  • Resmed's 5-year Debt to Equity high stood at $0.04 for Q3 2025, and its period low was $0.0 during Q2 2025.
  • In the last 5 years, Resmed's Debt to Equity had a median value of $0.0 in 2022 and averaged $0.01.
  • As far as peak fluctuations go, Resmed's Debt to Equity plummeted by 3101.74% in 2023, and later surged by 212890.49% in 2025.
  • Resmed's Debt to Equity (Quarter) stood at $0.0 in 2021, then tumbled by 30.57% to $0.0 in 2022, then decreased by 16.61% to $0.0 in 2023, then fell by 14.61% to $0.0 in 2024, then soared by 2080.46% to $0.04 in 2025.
  • Its last three reported values are $0.04 in Q4 2025, $0.04 for Q3 2025, and $0.0 during Q2 2025.